Back to speakers


Chief, division of Gastroenterology & Hepatology. Vincent Astor Professor of Medicine


City: New York

Institution: Weill Cornell Medical College


Biography of Ira JACOBSON

Dr. Jacobson earned his BS summa cum laude from Yale University and his MD from Columbia University College of Physicians and Surgeons. After completing an internship and residency at University of California San Francisco and a Fellowship in Gastroenterology at Massachusetts General Hospital and Harvard Medical School, in 1984 he joined the faculty at Weill Cornell Medical College, where he is currently Vincent Astor Distinguished Professor of Medicine, Chief of the Division of Gastroenterology and Hepatology, and Medical Director of the Center for the Study of Hepatitis C.


Dr. Jacobson is a Fellow of the American College of Physicians, American College of Gastroenterology, and American Gastroenterological Association, and a member of the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. In addition to maintaining an active practice with a focus on patients with liver disease, he has been an investigator in many trials on antiviral therapy for hepatitis B and C, including the pivotal trials on interferon-based therapy, since the 1980s. He has been lead principal investigator and author of a number of trials, including WIN-R trial (weight based ribavirin with peginterferon), ADVANCE (telaprevir), QUEST-1 (simeprevir), POSITRON (sofosbuvir), and STARTVerso3 (faldaprevir). He has served on the Gastroenterology and Transplant Hepatology Boards of the American Board of Internal Medicine, as Associate Editor of the Journal of Hepatology, and as a reviewer for several other journals. He has authored or co-authored over 200 peer-reviewed papers, chapters and reviews, including papers in the New England Journal of Medicine, Gastroenterology, Hepatology, Journal of Hepatology, Journal of Viral Hepatitis, Clinical Gastroenterology and Hepatology, and others. He has edited two books on ERCP and a volume on hepatitis B for Clinics in Liver Disease. He has co-chaired the annual Viral Hepatitis Congress in Frankfurt, Germany since 2012. Dr. Jacobson was recently named Co-Chief Medical Editor of HCV Next, a new publication from Slack Incorporated that also appears on

PHC's participations

5th PHC – 2012

Monday, January 30th 2012

Telaprevir -

6th PHC – 2013

Monday, January 14th 2013

Optimal treatment with telaprevir -

7th PHC – 2014

Monday, January 13th 2014

How to optimize current therapy of G1 patients (chairman)

Interactive luncheons - Room 6 (chairman)

8th PHC – 2015

Monday, January 12th 2015

New therapeutic strategies (chairman)